Healthcare · Drug Manufacturers - Specialty & Generic
InMed Pharmaceuticals Inc. operates as a clinical-stage pharmaceutical firm, concentrating its efforts on the investigation and creation of therapeutic solutions derived from cannabinoids.
52W Range
39thpctl
Volume
0.04×avg
Market Cap
7.31MUSD
P/E Ratio
-0.4TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
InMed Pharmaceuticals Inc.
INMNASDAQ Global Select·USD·Closed
InMed Pharmaceuticals Inc.
INMNASDAQ·USD·Closed
$1.33
−1.48%
$1.33
−$0.02 (1.48%)
52W Range
39thpctl
Volume
0.04×avg
Mkt Cap
7.31MUSD
P/E
-0.4TTM
Div Yield
–ann
INM: InMed Pharmaceuticals Inc. Stock Analysis | finqOS
